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Abstract
Background: In this work, the effect of the heat treatment on Ti6Al4V implants and topical administration of
growth hormone to address a better osseointegration in osteoporotic patients has been analysed.
Methods: The osseointegration process of Ti6Al4V implants modified by oxidation treatment at 700 °C for 1 h and
the influence of local administration of growth hormone (GH) in osteoporotic female rabbits after 15 and 30 days
of implantation have been studied. Bone response was analysed through densitometric and histomorphometric
studies. Characterization of the surface was provided by scanning electron microscopy.
Results: The oxidation treatment promotes the formation of an oxide scale grown on the Ti6Al4V implants that
alters the nanoroughness of the surface. Bone mineral density (BMD) increases from 0.347 ± 0.014 (commercial) to 0.
383 ± 0.012 g cm−2 (modified), and bone-to-implant contact (BIC) goes from 48.01 ± 14.78 (commercial) to 55.37 ±
15.31 (modified) after 30 days of implantation.
Conclusions: The oxidation treatment on the Ti6Al4V dental implants enhances the early bone formation at the
longest periods of implantation. No significant differences in the BMD and BIC results in healthy and osteoporotic
rabbits were revealed with respect to the local administration of GH in the implantation site.
Keywords: Growth hormone, Histomorphometry, In vivo, Oxidation treatment, Ti6Al4V
Background
The metallic biomaterials used in the substitution of hard
tissues are subjected to the action of the physiological en-
vironment and mechanical efforts like fatigue, wear or
friction that alter the operation success of implants and
affect drastically the electrochemical properties of the sur-
face. That is the case of Ti and its alloys, in which in vivo
conditions alter the stability of the passive layer and pro-
voke the release of both metallic ions and particles [1].
The search for new treatments that increase the wear
resistance, improve the bioactivity in order to facilitate
the formation of bone tissue around it and decrease the
titanium release is increasingly important. Among them,
thermal oxidation treatments aimed to obtain “in situ”
ceramic coatings can offer thick, highly crystalline oxide
films with very good protective performances [2, 3]. The
authors have proved that oxidation treatments of
Ti6Al4V alloy at 700 °C for 1 h provoke the formation of
an oxide layer, mainly composed of rutile [4] whose ion
release is reduced to the half [5]. In vitro experiments
with primary osteoblasts cell culture revealed that the
surface modification does not alter even improve the
excellent biocompatible behaviour. In fact, cell adhesion
is favoured on the thermally treated surfaces [6]. How-
ever, in vivo evidences have not been previously studied
by the authors. At the same way, sandblasting of
Ti6Al4V alloys in order to increase the roughness and
subsequent thermal treatment improves the osteoblast
response. The enhancement of the osseointegration
process can be achieved modifying the quality of the
surface of the implant in terms of chemical, physical and
* Correspondence: crisga@cenim.csic.es
4Department of Surface Engineering, Corrosion and Durability, National
Center for Metallurgical Research (CENIM), CSIC, Avda. Gregorio del Amo 8,
28040 Madrid, Spain
Full list of author information is available at the end of the article
International Journal of
Implant Dentistry
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Bodelón et al. International Journal of Implant Dentistry  (2016) 2:18 
DOI 10.1186/s40729-016-0051-5
topographical properties, all of them influencing the
functional activity of cells around the implant surface.
On the other hand, in those cases where there is a delay
in the physiological mechanisms of bone repair, either by
aging or due to problems of osteoporosis, the solution
must be taken by means of external substances that stimu-
late the bone metabolism. Patients diagnosed with sys-
temic diseases such as osteoporosis and diabetes are
considered to be medically compromised for implant ther-
apy. Research has been focused on the local application of
substances on the implant surface [7–9], or directly in the
implantation site, able to accelerate the osseointegration
process. Hormones [10–12], growth factors [13, 14] and
osseoconductive proteins [15] are being used to stimulate
the bone growth. Studies carried out by Becker et al. [16]
revealed that local application of diverse growth factors
(IGF-I and PDGF) induce the statistical increase in bone
repair and the increase of bone density, around Ti im-
plants, compared with the control group. Numerous stud-
ies highlight the importance of the growth hormone (GH)
in the repair of bone fractures as young as old animals.
The administration is able to increase up to 400 % the
mechanical properties with respect to the control group
[17, 18], stimulate the osteoblast activity and enhance the
bone neoformationa around implants [14].
The aim of this study is to study the influence of the
thermal treatment of Ti6Al4V dental implants and top-
ical administration of growth hormone on the osseointe-
gration process of osteoporotic rabbits during the first
month of implantation.
Methods
Implant preparation and characterization
Threaded commercial titanium alloy implants (3.3 mm
diameter and 8 mm length) from Zimmer® were used as
control implants. They consisted of Ti6Al4V screws blasted
with hydroxyapatite and subsequent acid attack with HCl.
Screws with these prior surface treatments were submitted
to a thermal treatment. The oxidation treatment was per-
formed at 700 °C for 1 h, in air. After oxidation, samples
were removed from the furnace and cooled at room
temperature. Commercial and heat-modified screws were
gamma-ray sterilized prior to implantation.
Scanning electron microscope (SEM) was used to
characterize the surface morphology of the Ti implants.
The surfaces were analysed by using a JEOL-6500F micro-
scope equipped with a field emission gun (FEG) coupled
with an energy dispersive X-ray (EDX) spectrometer. The
images were taken using secondary electrons.
Animals and treatment
The experimental protocol of this study and animal care
conformed to the European Communities Council Direct-
ive of 24 November 1986 (86/609/EEC) [19] and has been
independently reviewed and approved by the Madrid Com-
munity Ethics Committee for Regional Clinical Research
(CEIC-R). Forty New Zealand female rabbits of appro-
ximately 5 kg and 11 months old were chosen as experi-
mentation animals.
Animals were divided into healthy non-ovariectomised
group and ovariectomised (OVX) group to carry out the
tests. In order to induce osteoporosis, female rabbits
underwent bilateral ovariectomy under general anaesthe-
sia and were fed a hypocalcic diet (8.2 g kg−1 calcium and
6 g kg−1 phosphorous) for 8 weeks [20]. Diet mainly con-
sisted of 74.2 % barley, 20 % wheat bran, 5 % soy and
0.3 % salt was supplied by PanLab SL (Harvard Bioscience
Group, Barcelona, Spain). This procedure was selected
because the treatment based only on the ovariectomy and
hypocalcic diet provokes spontaneous fractures [21, 22].
Eight weeks post-surgery, rabbits were subjected to a
densitometry to the vertebral column and tibia bone to
verify the establishment of osteoporosis model [21]. For
the densitometric analysis, a Norland XR-26 densitom-
eter was used (Norland Co., Fort Atkinson, WI, USA)
calibrated prior to the measurement. The exploration
parameters were as follows: speed 40 mm s−1, resolution
1.0 × 1.0 mm, and measurement resolution 0.5 × 0.5 mm.
Forty percent of the total length of each bone was
analyzed, including metaphysis and diaphysis regions to
verify differences between bone mass of healthy and
osteoporotic groups. The value obtained was the bone
mineral density (BMD) in grammes per centimetre.
Implant procedure. Surgery
The experimental design carried out with the experimental
animals is summarized in Fig. 1. Rabbits were randomly di-
vided into two groups: control (healthy rabbits) and OVX
(osteoporotic rabbits). Both of them were subjected to sur-
gery to insert commercial (no thermally treated Ti6Al4V)
and modified (thermally treated Ti6Al4V) implants. The
half of the healthy and osteoporotic rabbits was treated with
4 IU of recombinant human growth hormone (rhGH) as ly-
ophilized powder (Genotonorm® Pfizer, NY, USA) directly
located in the place of insertion. Healthy and osteoporotic
rabbits without implants were also included as reference at
both implantation times in the study.
Incision was performed in the inner side of the prox-
imal epiphysis of each tibia, under intramuscular anaes-
thesia. Transcortical osteotomy followed by drilling to
generate a bed of 3.1 mm diameter and 8 mm deep was
made, where the implant was inserted until touching the
opposite cortical bone (Fig. 2). In the experimental
group with local GH, 4 IU of rhGH as powder was
added into the bone hole just before the insertion of the
Ti6Al4V implant. Commercial implant in the right tibia
and the modified implant in the left tibia were inserted.
Only one implant was inserted in each tibia.
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The injury was sutured with absorbable material after
the implantation. Antibiotics and anti-inflammatory agents
were delivered in the postoperative period to prevent infec-
tion and pain. Rabbits were sacrificed after 15 and 30 days
of implantation by intravenous injection of 0.4 mg sodium
pentobarbital (Dolethal®, Vetoquinol, Cedex, Francia) di-
luted in serum (Fig. 1).
Tibiae were cleaned from soft tissues to determine
the bone mineral density (BMD). Densitometries at
0.5 mm above and 0.5 mm below the Ti6Al4V implant
were acquired to compare the BMD of control and
OVX groups.
Histological study of each tibia (including the Ti6Al4V
implant) for control and modified implants and with and
without GH was carried out. Clean hard tissues were
fixed in 10 % pH 7 buffered formaldehyde and dehy-
drated in grading alcohol concentrations. Tibiae were
cut into blocks and histologically prepared according to
the modified Donath and Breuner method [23]. The
preparation of hard tissue consisted of embedding in
light-polymerizing 2-hydroxietyl-metacrylate. These blocks
were cutting in five sections of about 200 μm and then
grinding until achieving cross-sections of about 80-μm final
thicknesses with an EXAKT cutting and grinding equip-
ment (EXAKT, Norderstedt, Germany).
Bone-implant interface sections were examined under
the optical microscope (Zeiss, Oberkpchen, Germany)
using histological laboratory stains such as toluidine blue
with Weigert haematoxylin (Merck, Kenilworth, NJ,
USA) that allows the differentiation between osteoblasts
and osteoclasts [24].
The images were processed and cross-sections were
compared by means of the MIP-4 image analyser soft-
ware (Digital Image Systems, SL, Barcelona) in order to
quantify the bone fraction. The MIP-4 software is able
to perform area and volume measurements through a
computerized system connected to the optical micro-
scope and histological lens. Area and length measure-
ments on the images captured from the microscope
were attained. All images were processed with ×10 mag-
nification objective. The bone-to-implant contact (BIC)
Fig. 1 Schematic diagram of the classification of experimental animals in groups
Fig. 2 Transcortical osteotomy with Ti6Al4V implant inserted in the
tibia bone
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is calculated as the ratio of the length of the implant in
contact to bone tissue and the implant perimeter, i.e. the
percentage of the implant surface in contact with bone.
The quantitative results were processed with the statis-
tical package Statgraphics plus 5.1. The significance of
the differences between the groups was studied accord-
ing to Student’s t test and the one-way ANOVA test
(analysis of variance). p value was 0.05.
Results
Figure 3 shows images at different magnifications by
SEM of the typical threaded topography of the Ti6Al4V
screws and the characteristic surface with cavities and
holes heterogeneously dispersed due to the impingement
of the particles used in the blasting process. The chem-
ical analysis performed by EDX of a representative area
(Table 1) shows the characteristics peaks of Ti, Al
and V, together with some proportion of Ca and P.
Ca and P came from the hydroxyapatite particles used
in the blasting process.
Due to this process, it is unavoidable that the blasting
particles induces abrasive pollution on the surface, giving
rise to a surface modification not only in the final rough-
ness but also in the chemical composition, that influences
the physicochemical properties of the blasted surfaces
[25]. To minimize the drastic changes produced by of the
blasting process, the posterior acid attack is usually used
as a method to smooth titanium surfaces and also to elim-
inate the residual particles resulting from the blasting
process [26]. The use of HCl posterior to the blasting
process does not assure that residual hydroxyapatite parti-
cles remain incrusted in the surface of the implants.
Nevertheless, given the chemical nature of the Ca-P com-
pounds on the surface, its presence could be even consid-
ered as beneficial in the osseointegration process.
After the thermal treatment, an oxide scale is grown on
the Ti6Al4V screws (Fig. 4). Barranco et al. [27] established
that the increase in roughness (at microscale) of specimens
due to the thermal treatment at 700 °C for 1 h was not sig-
nificant. However, the nanoroughness of the surface can be
Fig. 3 SEM image of the surface of control commercial Ti6Al4V dental implants
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increased about 140 nm due to this treatment [27] (com-
pare Figs. 3 and 4). The thermal oxidation of the Ti6Al4V
alloy after oxidation treatment at 700 °C for 1 h gives rise
to a modified surface whose composition and crystalline
order is changed. Previous XRD results of Ti6Al4V ther-
mally treated at 700 °C for 1 h carried out by the authors
and published in Billi et al. [28] revealed diffraction angles
assigned to rutile, without any evidence of aluminium
oxide. Confidence about the stability of the microstructure
during the thermal oxidation treatments was provided in
previous works by no significant differences in hardness
from 329 to 320 HV0.5 after 700 °C for 1 h [4].
Table 2 shows the estimated mean values and standard
deviations for the BMD in healthy (control) and osteo-
porotic (OVX) rabbits. The comparison of mean values
established significant differences between control and
OVX groups (p = 0.006). The BMD results show that the
ovariectomy and hypocalcic diet described in (20) resulted
being proper methods to have osteoporotic rabbits before
the insertion of implants in the tibiae.
After insertion of the implants, BMD of above and
below implant areas in tibiae with and without the local
application of GH for each rabbit group (control and
OVX) was measured at 15 and 30 days. As an example,
means (grammes per square centimetre) and standard
deviations in control and OVX rabbits after 15 days
appear in Table 3.
BMD values indicate that there are no significant statis-
tical differences either above or below the implant areas,
in metaphysis and diaphysis regions, independently on the
variables studied: type of implant (commercial or mo-
dified) and addition of GH local administration in the
implantation site.
In general, after 30 days, in OVX group, BMD results
show that the modification of the surface by the thermal
treatment gives rise to a significant better bone response
(p = 0.016) (Fig. 5).
In agreement with the BMD results, the BIC values
show no significant statistical differences independently
on the local administration of GH in the implantation
site and previous oxidation treatment of the implant.
Figure 6 shows the results of BIC values of thermally
treated and control implants in OVX rabbits (with and
without GH) after 15 and 30 days. We found a small
non-significant difference in BIC results in the osteopor-
otic group affecting the osseointegration response after
15 and 30 days of implantation period, mainly related to
the previous thermal treatment applied on the implants.
Nevertheless, all ANOVA values were higher than 0.05
so no significant differences were found at any condition
at 95 % confidence level.
Discussion
A good preparation of the implant surface in order to
accommodate bone topographical features contributes to
accelerate the assembly between the new bone formed and
the metallic implant. Research has been consequently
Fig. 4 SEM image of the nanoroughness of the oxidized surfaces on
control Ti6Al4V dental implants after 700 °C for 1 h
Table 2 Mean (grammes per square centimetre) and standard
deviations of the bone mineral density (BMD) of tibiae and
vertebral column in healthy (control) and osteoporotic
(OVX) rabbits
Animal group BMD (g cm−2) tibiae BMD (g cm−2) vertebral column
Control 0.323 ± 0.014 0.285 ± 0.007
OVX 0.301 ± 0.016 0.271 ± 0.009
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focused on the surface modifications of implants aimed to
simulate the size of the proteins or cell membrane re-
ceptors. In vitro results about the influence of different
micro-nanoscale roughness on the osteoblast differenti-
ation are sometimes contradictory [29, 30]. This is
probably due to the differences between the types of
cells and the types of nanoscale surface modifications
used in these experiments [31]. So, the definitive con-
firmation should be given by in vivo studies. In this
work, the in vivo study about the use of oxidation tre-
atments to modify the nanoroughness on the previous
micro-scale roughness of the implant surface has proved
to accelerate the osseointegration process.
The morphometric measurement of the BIC of osseoin-
tegrated implants is the standard procedure for the evalu-
ation of bone formation on an implant surface. High BIC
values are considered to be a prerequisite for implant
stability, which clinically enables functional dental recon-
struction. Studies evaluating new implant surfaces assess
this parameter. In particular, differences in BIC between
test and reference surfaces are statistically analysed to
compare their osteogenic potential. Nevertheless, it is
interesting to remark that the use of two (or even only
one) histological sections per implant may strongly influ-
ence the determined BIC [32].
In our work, densitometric and morphometric studies
point to a better bone response to the Ti6Al4V commer-
cial implants thermally treated at 700 °C for 1 h (Figs. 5
and 6). The highest BIC value achieved for the thermally
treated implant after 30 days of implantation (especially
in the OVX rabbit group) could be explained by consid-
ering different features on the oxidized surface such as
chemical composition and topographical properties. The
chemical composition of the oxidized surface after heat
treatment at 700 °C for 1 h, verified by XRD, is rutile
[28], which is formed on the free-particle areas of the
Ti6Al4V surface. Rutile scale has been proved to en-
hance the osteoblast response [4], improve the resistance
to pitting corrosion [27] and decrease the ion release of
the Ti6Al4V [5].
In addition, the morphology of the hard rutile scale
grown on the implant surface increases nanoroughness
(Fig. 4). Studies carried out by Webster et al. [29] have
pointed out the importance of the surface roughness at
the nanometre range in the connectivity to bone. It has
been discussed that the increase of micro- and submicro-
scale surface roughness, with feature sizes comparable to
those of resorption pits of bone and cell dimensions, leads
to enhanced osteoblasts differentiation and increased
bone-to-implant contact in vivo [33].
Table 3 Means (grammes per square centimetre) and standard deviations of the bone mineral density (BMD) of above and below




Without GH With GH Without GH With GH
Control Above 0.356 ± 0.017 0.368 ± 0.036 0.382 ± 0.006 0.351 ± 0.021
Below 0.366 ± 0.008 0.372 ± 0.029 0.374 ± 0.031 0.366 ± 0.015
OVX Above 0.308 ± 0.024 0.348 ± 0.019 0.357 ± 0.053 0.345 ± 0.027
Below 0.369 ± 0.027 0.343 ± 0.011 0.363 ± 0.032 0.330 ± 0.024
Fig. 5 Bone mineral density (BMD) values in osteoporotic (OVX) rabbits after 30 days of implantation of both commercial and modified implants.
Vertical lines represent standard deviations
Bodelón et al. International Journal of Implant Dentistry  (2016) 2:18 Page 6 of 9
In the specific case of osteoporotic rabbits, the results
showed that the modification of the surface by the ther-
mal treatment gives rise to a better bone response in
BMD and BIC values at longer time of implantation, i.e.,
30 days (Figs. 5 and 6). These results seem to indicate
that the crystallography and the chemical composition
given by the rutile enhance the interaction between oste-
oblasts and surface improving the bone regeneration
around the Ti6Al4V implants.
With respect to local administration of GH to the osteo-
porotic rabbits, significant results have not been obtained,
although a slight improvement was observed. In our
study, densitometric results related to those animals in the
GH treated group that were sacrificed after 15 days
showed a tendency towards increased bone mineral dens-
ity (BMD) that did not reach statistical significance. Our
results emphasize the idea of the variability in the re-
sponse to GH because, by itself, topical administration
gives rise to very different results probably due to add-
itional characteristics that affect to variables such as the
host, the methodology of administration of GH or the
implant itself. These results are in agreement with the
authors’ previous data [11] and other authors [34]. For
example, Calvo-Guirado et al. [14] found topical applica-
tion of 4 IU of GH like biomimetic agent at the moment
of implant placement has no significant effects on the BIC
at 5 and 8 weeks, although bone formation and inter-
thread bone values did increase significantly. However,
controversial about the efficiency of the topical adminis-
tration of GH is found in the literature. Munoz et al. [35]
found that topical application of growth hormone GH and
melatonin synergistically enhance new bone formation
around titanium implants in early stages of healing.
During the first period of 15 days, the rabbit biokinetics
is appropriate to initiate a formation of young bone, which
can be confirmed or not, at 30 days. In this animal model,
the bone formation can be initiated before 15 days, as has
been seen in other studies, but it is very spars. Moreover,
the first days guide us towards an evolution of the bone
response that is confirmed at 15 days. It has been pub-
lished in previous works [10] that the fast periosteal
response found could be explained by direct action of GH
on the pluripotential mesenchymal cells in the first steps
of the repair process. The GH accelerated this process in
what has been called the “impulse effect” stimulating
osteoblasts, chondroblasts, and fibroblasts. However, the
most authors have not statistically found a response to
GH dependent dose [10, 12], asseveration that is in ac-
cordance with our data.
Systemic and local administration of growth factors
accelerates bone regeneration [36] and promotes osteoin-
ductive effects [37]. In fact, the systemic administration of
GH has shown to accelerate fracture healing [38] at longer
periods of implantation. The beneficial role of GH on the
bone regeneration could be achieved at initial local admin-
istration of GH in the implantation site where oxidized
Ti6Al4V implant is located and after a critical period of
implantation time, systemic administration by means of
small regular dose, according to [38].
Conclusions
In summary, oxidation treatments of Ti6Al4V dental
implants stimulate a better bone response at longer im-
plantation times. The local application of GH on the
implantation site showed no significant effect in the
osseointegration process (from BMD and BIC measu-
rements) of thermal and commercial Ti6Al4V dental
implants during the first month of implantation.
Funding
The authors acknowledge the source of funding received from
Ministerio de Economia y Competitividad (Spain) through the
MAT2011-29152-C02-01 project.
Fig. 6 Bone to implant contact (BIC) values (%) for commercial and modified implants in osteoporotic (OVX) rabbits after 15 and 30 days of
implantation. Vertical lines represent standard deviations
Bodelón et al. International Journal of Implant Dentistry  (2016) 2:18 Page 7 of 9
Availability of data and materials
Data supporting will be available in digital.csic.es repository.
Competing interests
Oscar G. Bodelón, Celia Clemente, Miguel Angel Alobera, Soledad
Aguado-Henche, María Lorenza Escudero and María Cristina García
Alonso declare that they have no competing interests.
Authors’ contributions
OGB participated in the design of the study, helped to the characterization
of the implants, performed the statistical analysis and helped to draft the
manuscript. CC helped to the surgery and performed the analysis and
interpretation of histomorphometric data. MAA carried out the surgery and
helped to the interpretation of data. SAH carried out the densitometric tests
and helped to the analysis and interpretation of densitometric data. MLE
participated in the design of the study, coordination of tests and helped to
draft the manuscript. MCGA participated in the design of the study,
characterization of the implants, carried out the coordination of results and
headed the draft the manuscript. All authors read and approved the final
manuscript.
Author details
1Department of Characterization, Quality and Safety, Institute of Food
Science, Technology and Nutrition (ICTAN-CSIC), Madrid, Spain. 2Department
of Human Anatomy and Embryology, School of Medicine, University of
Alcalá, Alcalá de Henares, Spain. 3Stomatology Department IV, Complutense
University of Madrid (UCM), Madrid, Spain. 4Department of Surface
Engineering, Corrosion and Durability, National Center for Metallurgical
Research (CENIM), CSIC, Avda. Gregorio del Amo 8, 28040 Madrid, Spain.
Received: 2 April 2016 Accepted: 7 July 2016
References
1. Lomholt TC, Pantleon K, Somers MAJ. In-vivo degradation mechanism of
Ti-6Al-4V hip joints. Mater Sci Eng C. 2011;31:120–7.
2. Wisbey A, Gregson PJ, Peter LM, et al. Effect of surface treatment on the
dissolution of titanium-based implant materials. Biomaterials. 1991;12:470–3.
3. Chen G, Wen X, Zhang N. Corrosion resistance and ion dissolution of
titanium with different surface microroughness. Biomed Mater Eng.
1998;8:61–74.
4. Garcia-Alonso MC, Saldana L, Valles G, et al. In vitro corrosion behaviour
and osteoblast response of thermally oxidised Ti6Al4V alloy.
Biomaterials. 2003;24:19–26.
5. Saldaña L, Barranco V, García-Alonso MC, et al. Concentration-dependent
effects of titanium and aluminium ions released from thermally oxidized
Ti6Al4V alloy on human osteoblasts. J Biomed Mater Res. 2006;77A:220–9.
6. Saldaña L, Vilaboa N, Vallés G, et al. Osteoblast response to thermally
oxidized Ti6Al4V alloy. J Biomed Mater Res. 2005;73A:97–107.
7. Zhang L, Wu K, Song W, et al. Chitosan/siCkip-1 biofunctionalized titanium
implant for improved osseointegration in the osteoporotic condition.
Scientific Reports. 2015;5:10860.
8. Kammerer PW, Lehnert M, Al-Nawas B, et al. Osseoconductivity of a specific
streptavidin-biotin-fibronectin surface coating of biotinylated titanium
implants - a rabbit animal study. Clin Implant Dent Relat Res. 2015;17 Suppl
2:e601–12.
9. Germanier Y, Tosatti S, Broggini N, et al. Enhanced bone apposition
around biofunctionalized sandblasted and acid-etched titanium implant
surfaces A histomorphometric study in miniature pigs. Clin Oral Impl
Res. 2006;17:251–7.
10. Tresguerres IF, Clemente C, Donado M, et al. Local administration of growth
hormone enhances periimplant bone reaction in an osteoporotic rabbit
model. An histologic, histomorphometric and densitometric study. Clin Oral
Impl Res. 2002;13:631–6.
11. Tresguerres IF, Blanco L, Clemente C, et al. Effects of local administration of
growth hormone in periimplant bone: an experimental study with implants
in rabbit tibiae. Int J Oral Maxillofac Implants. 2003;18:807–11.
12. Tresguerres IF, Alobera MA, Baca R, et al. Histologic, morphometric,
and densitometric study of peri-implant bone in rabbits with local
administration of growth hormone. Int J Oral Maxillofac Implants.
2005;20:193–202.
13. Lynch S, Buser D, Hernández RA, et al. Effects of the platelet derived growth
factor insulin-like growth factor-I combination on bone regeneration
around titanium dental implants. Results of a pilot study in beagle dogs.
J Periodontol. 1991;62:710–6.
14. Calvo-Guirado JL, Mate-Sanchez J, Delgado-Ruiz R, et al. Effects of growth
hormone on initial bone formation around dental implants: a dog study.
Clin Oral Impl Res. 2011;22:587–93.
15. Oryan A, Alidadi S, MoshirI A, et al. Bone morphogenetic proteins: a
powerful osteoinductive compound with non-negligible side effects and
limitations. Biofactors. 2014;40:459–81.
16. Becker W, Linch SE, Lekholm U, et al. A comparison of e-PTFE
membranes alone or in combination with platelet-derived growth
factors and insulin-like growth factor-I or demineralized freeze-dried
bone in promoting bone formation around immediate extraction
socket implants. Periodontol. 1992;63:929–40.
17. Bak B, Andreassen TT. The effect of growth hormone on fracture healing in
old rats. Bone. 1991;12:151–4.
18. Andreassen TT, Jorgensen PH, Flyvbjerg A, et al. Growth hormone
stimulates bone formation and strength of cortical bone in aged rats.
J Bone Miner Res. 1995;10:1057–67.
19. European Parliament and Council. Council Directive 86/609/EEC of 24
November 1986 on the protection of animals used for experimental and
other scientific purposes. Official J Eur Communities. 1986;L358:1–28.
20. Committee on Animal Nutrition; Board on Agriculture and Renewable
Resources; National Research Council. Nutrient Requirements of Rabbit. 2nd
rev. ed. Washington DC: National Academic of Sciences; 1977.
21. Vidigal Jr GM, Groisman M, Gregorio LH, et al. Osseointegration of titanium
alloy and HA-coated implants in healthy and ovariectomized animals: a
histomorphometric study. Clin Oral Impl Res. 2009;20:1272–7.
22. Martin-Monge E, Tresguerres IF, Blanco L, et al. Validation of an osteoporotic
animal model for dental implant analyses: an in vivo densitometric study in
rabbits. Int J Oral Maxillofac Implants. 2011;26:725–30.
23. Donath K, Breuner G. A method for the study of undecalcified bones and
teeth with attached soft tissues. J Oral Pathol. 1982;11:318–26.
24. Chappard D, Baslé MF, Legrand E, et al. New laboratory tools in the
assessment of bone quality. Osteoporos Int. 2011;22:2225–40.
25. Barranco V, Escudero ML, Garcia-Alonso MC. 3D, chemical and
electrochemical characterization of blasted Ti6Al4V surfaces: Its influence on
the corrosion behavior. Electrochim Acta. 2007;52:4374–84.
26. Diniz MG, Soares GA, Coelho MJ, et al. Surface topography modulates the
oeteogenesis in human bone marrow cell cultures grown on titanium
samples prepared by a combination of mechanical and acid treatments.
J Mater Sci. 2002;13:421–32.
27. Barranco V, Onofre E, Escudero ML, et al. Characterization of roughness and
pitting corrosion of surfaces modified by blasting and thermal oxidation.
Surf Coat Tech. 2010;204:3783–93.
28. Billi F, Onofre E, Ebramzadeh E, et al. Characterization of modified Ti6Al4V
alloy after fretting–corrosion tests using near-field microscopy. Surf Coat
Tech. 2012;212:134–44.
29. Webster TJ, Ejiofor JU. Increased osteoblasts adhesion on nanophase metals:
Ti. Ti6Al4V and CoCrMo. Biomaterials. 2004;25:4731–9.
30. Cai KY, Bossert J, Jandt KD. Does the nanometer scale topography of
titanium influence protein adsorption and cell proliferation? Colloids Surf B:
Biointerfaces. 2006;49:136–44.
31. Gittens RA, McLachlan T, Olivares-Navarrete R, et al. The effects of
combined micron-submicron scale surface roughness and nanoscale
features on cell proliferation and differentiation. Biomaterials.
2011;32:3395–403.
32. Bernhardt R, Kuhlisch E, Schulz MC, et al. Comparison of bone-implant
contact and bone-implant volume between 2d-histological sections and
3D-SR-μCT slices. Eur Cells Mater. 2012;23:237–48.
33. Cochran DL, Schenk RK, Lussi A, et al. Bone response to unloaded and
loaded titanium implants with a sandblasted and acid-etched surface:
a histometric study in the canine mandibule. J Biomed Mater Res.
1998;40:1–11.
34. Lutz R, Srour S, Nonhoff J, et al. Biofunctionalization of titanium implants
with a biomimetic active peptide (P-15) promotes early osseointegration.
Clin Oral Imp Res. 2010;21:726–34.
35. Muñoz F, López-Peña M, Miño N, et al. Topical application of melatonin and
growth hormone accelerates bone healing around dental implants in dogs.
Clin Oral Imp Res. 2012;14:226–35.
Bodelón et al. International Journal of Implant Dentistry  (2016) 2:18 Page 8 of 9
36. Raschke MJ, Bail H, Windhagen HJ, et al. Recombinant growth hormone
accelerates bone regenerate consolidation in distraction osteogenesis. Bone.
1999;24:81–8.
37. Schmidmaier G, Wildemann B, Bail H, et al. Local application of growth
factors (insulin-like growth factor-1 and transforming growth factor-β1) from
a biodegradable poly(D, L-lactide) coating of osteosynthetic implants
accelerates fracture healing in rats. Bone. 2001;28:341–50.
38. Schmidmaier G, Wildemann B, Heeger J, et al. Improvement of fracture
healing by systemic administration of growth hormone and local
application of insulin-like growth factor-1 and transforming growth
factor-β1. Bone. 2002;31:165–72.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Bodelón et al. International Journal of Implant Dentistry  (2016) 2:18 Page 9 of 9
